Table 5.
Comparison of different procedures in their efficacy in improving glycaemic control
| Parameter | Procedure | At the time of registration | At the time of follow-up |
|---|---|---|---|
| n=156 (%) | |||
| Oral pharmacotherapy | LSG | 83.5 | 24.7 |
| RYGB | 90.9 | 36.4 | |
| OAGB | 86.7 | 0 | |
| Insulin use | LSG | 15.5 | 5.2 |
| RYGB | 29.6 | 4.6 | |
| OAGB | 20 | 0 | |
| n=96 | |||
| BMI (kg/m2) | LSG | 45.7±9.3 | 34.7±7.7 |
| RYGB | 44.5±6.0 | 32.7±5.4 | |
| OAGB | 49.1±5.0 | 33.8±6.4 | |
| Fasting glucose (mg/dl) | LSG | 132.9±54.8 | 108.6±31.6 |
| RYGB | 141.5±54.0 | 106.8±29.0 | |
| OAGB | 130.7±27.8 | 85.1±18.7 | |
| A1C (%) | LSG | 7.7±1.5 | 6.5±1.5 |
| RYGB | 8.2±2.1 | 6.4±1.3 | |
| OAGB | 7.3±1.0 | 6.0±1.2 |
For each of these investigations, P value between follow-up results of LSG and RYGB was not significant. BMI: Body mass index, LSG: Laparoscopic sleeve gastrectomy, RYGB: Roux-en-Y bypass, OAGB: One-anastomosis gastric bypass, A1C: Glycosylated haemoglobin. Number of diabetic patients considered=244. Number of patients who could be contacted at the time of follow-up=156. LSG: 97 patients, RYGB: 44 patients, OAGB: 15 patients. Number of patients with biochemical investigations at the time of follow-up=96. LSG: 54 patients, RYGB: 35 patients, OAGB: 7 patients